Vaccine April 2024 PMID 38503664

CHO cells for virus-like particle and subunit vaccine manufacturing.

Zalma V Sanchez-Martinez, Sergio P Alpuche-Lazcano, Matthew Stuible, Yves Durocher

Mentions

9
Peak: 3 in Nov 2025
across 4 sources since Mar 2024

Extended reach

1,246
potential audience

Total likes

2

Video views

398

Mentions per month

Mar 2024 – Nov 2025

Where it's discussed

  • X / Twitter3 posts
  • News3 articles
  • YouTube2 videos
  • LinkedIn1 posts

AI synopsis

What people are saying

The posts reflect a balanced view, highlighting the potential of CHO cells in vaccine development, with phrases like 'exciting advancements' and '#CHOcells #Bioprocess' demonstrating moderate enthusiasm and recognition of significance. The tone is mostly optimistic yet concise, indicating a general awareness of the topic's importance without deep technical debate.

AgreementModerate agreement

The posts seem generally positive and supportive of the research developments, indicating mild to moderate agreement.

InterestModerate interest

Discussion points show some curiosity about the advancements in CHO cell technology and vaccine production, though not intensely detailed.

EngagementNeutral engagement

The posts are brief and lack deep analysis but acknowledge the importance of the advancements.

ImpactModerate impact

The postings imply that this research could influence vaccine manufacturing practices, though the discussion remains surface-level.

Abstract in brief

  • Chinese Hamster Ovary (CHO) cells, traditionally used for manufacturing monoclonal antibodies and therapeutic proteins, are now increasingly being utilized to produce vaccine antigens.
  • Recent advancements include CHO cell-derived subunit vaccines for respiratory syncytial virus (RSV) and varicella-zoster virus (VZV), as well as enveloped virus-like particle (eVLP) vaccines for hepatitis B virus (HBV), with ongoing preclinical and clinical development.
  • Challenges in vaccine production using CHO cells involve ensuring viral clearance, especially for eVLP products, but recent progress demonstrates their potential as effective vaccine platforms.]

Top posts

Most liked on X and Bluesky
Phage Papers
@Phage_Papers · X

CHO cells for virus-like particle and subunit vaccine manufacturing https://t.co/3ziwa103AC

Mar 20, 2024 · 645 followers View post →
CHO Cell Papers
@CHOculturePaper · X

Oct 27, 2025 · 82 followers View post →

All mentions

CHO Cell Papers
@CHOculturePaper · X

Oct 27, 2025 · 82 followers View post →
CHO Cell Papers
@CHOculturePaper · X

CHO cells for virus-like particle and subunit vaccine manufacturing. Vaccine(2024) #CHOcells #Bioprocess https://t.co/M1rTjcNPQt

Aug 24, 2025 · 82 followers View post →
Phage Papers
@Phage_Papers · X

CHO cells for virus-like particle and subunit vaccine manufacturing https://t.co/3ziwa103AC

Mar 20, 2024 · 645 followers View post →
Mammalian Cells in Culture Frequently Release Type C Viruses ...
News

CHO cells for virus-like particle and subunit vaccine manufacturing, Vaccine, 42, 10, (2530-2542), (2024).https://doi.org/10.1016/j.vaccine.2024.03.034.

Dec 15, 2025 View →
Ats 2025 Clinical Year in Review | PDF | Asthma | Respiratory ...
News

Exacerbations. Chest. 2024 Aug;166(2):294-303. doi: 10.1016/j.chest.2024.03.034 95% CI, 0.61 ...

Mar 25, 2025 View →
Physiological Markers For Immunotherapeutics A Review | PDF ...
News

in vaccine development is less widespread compared treatment. ITM ... doi: 10.1016/j.jaip.2024.03.034. and validation of blood-based ...

Mar 24, 2025 View →
I'm so excited to share with you our latest review paper, where we ...
LinkedIn

... CHO cells as substrates to produce recombinant protein-based vaccines Go check it out here! https://lnkd.in/gFvppGmt.

Mar 20, 2024 View →